<DOC>
	<DOCNO>NCT00000597</DOCNO>
	<brief_summary>To determine therapeutic effect anti-thymocyte globulin ( ATG ) patient aplastic anemia related bone marrow failure disease .</brief_summary>
	<brief_title>Multi-Center Trial Anti-Thymocyte Globulin Treatment Aplastic Anemia Other Hematologic Disorders</brief_title>
	<detailed_description>BACKGROUND : Aplastic anemia show respond ATG . An immunological basis aplastic anemia suggest previous observation although precise mechanism action ATG define . This serum , produce immunization horse human thymocytes , may broad reactivity many human cell . DESIGN NARRATIVE : Patients Group I acute severe disease randomize receive ATG either ten day twenty-eight day course . Patients Group II moderate chronic disease randomize receive either ATG ten day high dos androgen , nandrolone decanoate . Patients Group III variety bone marrow disease also treat ATG . The study completion date list record infer last publication list Citations section study record .</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Hematologic Diseases</mesh_term>
	<mesh_term>Anemia , Aplastic</mesh_term>
	<mesh_term>Pancytopenia</mesh_term>
	<mesh_term>Antilymphocyte Serum</mesh_term>
	<mesh_term>Nandrolone</mesh_term>
	<criteria>Men woman moderate acute , severe , aplastic anemia .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2000</verification_date>
</DOC>